ImaginAb is awarded NCI SBIR contract in support of its work with huJ591/Prostate-Specific Membrane Antigen (PSMA)
ImaginAb is awarded NCI SBIR contract in support of its work with huJ591/Prostate-Specific Membrane Antigen (PSMA). ImaginAb will generate a diagnostic imaging agent to fill a major unmet clinical need in the diagnosis and treatment of prostate cancer.
